BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, Holmvang L, Clemmensen P, Engstrøm T, Grande P, Saunamäki K, Jørgensen E. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol 2014;64:2101-8. [PMID: 25457398 DOI: 10.1016/j.jacc.2014.08.037] [Cited by in Crossref: 196] [Cited by in F6Publishing: 156] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Moulin K, Viallon M, Romero W, Chazot A, Mewton N, Isaaz K, Croisille P. MRI of Reperfused Acute Myocardial Infarction Edema: ADC Quantification versus T1 and T2 Mapping. Radiology 2020;295:542-9. [PMID: 32208095 DOI: 10.1148/radiol.2020192186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
2 Frederix I, Dendale P, Schmid J. Who needs secondary prevention? Eur J Prev Cardiolog 2017;24:8-13. [DOI: 10.1177/2047487317706112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
3 Bromage DI, Yellon DM. The pleiotropic effects of metformin: time for prospective studies. Cardiovasc Diabetol 2015;14:109. [PMID: 26271457 DOI: 10.1186/s12933-015-0273-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
4 Balen F, Lhermusier T, Grolleau S, Pélissier F, Dehours E, Charpentier S, Azema O, Lamy S; RESCAMIP investigators. Identifying key factors leading to the optimal care pathway for patients with ST-segment elevation myocardial infarction: Results from the RESCAMIP registry. Arch Cardiovasc Dis 2019;112:374-80. [PMID: 31160206 DOI: 10.1016/j.acvd.2019.01.004] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Reindl M, Feistritzer HJ, Reinstadler SJ, Mueller L, Tiller C, Brenner C, Mayr A, Henninger B, Mair J, Klug G, Metzler B. Thyroid-stimulating hormone and adverse left ventricular remodeling following ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care 2019;8:717-26. [PMID: 29637788 DOI: 10.1177/2048872618770600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Faria DC, Santos MB, Abreu PFE. The fall in acute coronary syndrome admissions during the COVID-19 Portuguese lockdown. Rev Port Cardiol (Engl Ed) 2021;40:251. [PMID: 33478846 DOI: 10.1016/j.repc.2020.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Rossello X, Pocock SJ, Julian DG. Long-Term Use of Cardiovascular Drugs: Challenges for Research and for Patient Care. J Am Coll Cardiol 2015;66:1273-85. [PMID: 26361160 DOI: 10.1016/j.jacc.2015.07.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 11.7] [Reference Citation Analysis]
8 Carpeggiani C, Rossi G, Landi P, Michelassi C, Brambilla M, Cortigiani L, Picano E. Long-term outcome and medical radiation exposure in patients hospitalized for cardiovascular disease. International Journal of Cardiology 2015;195:30-6. [DOI: 10.1016/j.ijcard.2015.05.080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
9 Huang B, Huang F, Zuo Z, Liao Y, Heng Y, Wang P, Gui Y, Xia T, Xin Z, Liu W, Zhang C, Chen S, Pu X, Chen M, Huang D. Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology 2015;115:1529-38. [DOI: 10.1016/j.amjcard.2015.02.057] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
10 Pavasini R, Biscaglia S, Barbato E, Tebaldi M, Dudek D, Escaned J, Casella G, Santarelli A, Guiducci V, Gutierrez-Ibanes E, Di Pasquale G, Politi L, Saglietto A, D'Ascenzo F, Campo G. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J 2020;41:4103-10. [PMID: 31891653 DOI: 10.1093/eurheartj/ehz896] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 27.0] [Reference Citation Analysis]
11 Gao S, Liu Q, Ding X, Chen H, Zhao X, Li H. Predictive Value of the Acute-to-Chronic Glycemic Ratio for In-Hospital Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Angiology 2020;71:38-47. [PMID: 31554413 DOI: 10.1177/0003319719875632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions. Circulation 2018;137:1949-64. [PMID: 29712696 DOI: 10.1161/CIRCULATIONAHA.117.030693] [Cited by in Crossref: 58] [Cited by in F6Publishing: 20] [Article Influence: 29.0] [Reference Citation Analysis]
13 Joshi FR, Pedersen F, Räder S, Raunsø J, Kjaergaard J, Lindholm M, Hassager C, Engstrøm T, Holmvang L, Helqvist S, Jørgensen E. Jeopardized Myocardium and Survival in Patients Presenting to the Catheterization Laboratory With ST-Elevation Myocardial Infarction and Shock. Cardiovascular Revascularization Medicine 2020;21:843-8. [DOI: 10.1016/j.carrev.2019.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Takahashi M, Kondo Y, Senoo K, Fujimoto Y, Kobayashi Y. Incidence and prognosis of cardiopulmonary arrest due to acute myocardial infarction in 85 consecutive patients. Journal of Cardiology 2018;72:343-9. [DOI: 10.1016/j.jjcc.2018.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
15 Abu-assi E, Bernal JL, Raposeiras-roubin S, Elola FJ, Fernández Pérez C, Íñiguez-romo A. Tendencias e impacto pronóstico de la duración de la estancia hospitalaria en el infarto de miocardio con elevación del segmento ST no complicado en España. Revista Española de Cardiología 2020;73:479-87. [DOI: 10.1016/j.recesp.2019.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Falkentoft AC, Rørth R, Iversen K, Høfsten DE, Kelbæk H, Holmvang L, Frydland M, Schoos MM, Helqvist S, Axelsson A, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Pedersen F, Torp-Pedersen C, Kofoed KF, Goetze JP, Engstrøm T, Køber L. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. J Am Heart Assoc 2018;7:e008123. [PMID: 29776961 DOI: 10.1161/JAHA.117.008123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
17 Malmborg M, Christiansen CB, Schmiegelow MD, Torp-Pedersen C, Gislason G, Schou M. Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study. BMC Cardiovasc Disord 2018;18:198. [PMID: 30348102 DOI: 10.1186/s12872-018-0932-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
18 Rossello X, Bueno H, Pocock SJ, Van de Werf F, Danchin N, Annemans L, Medina J, Zeymer U. Predictors of all-cause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: Results from the EPICOR registry. Clin Cardiol 2019;42:111-9. [PMID: 30443916 DOI: 10.1002/clc.23116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
19 Lønborg J, Engstrøm T. Cardiovascular Magnetic Resonance for Risk Stratification in Patients With ST-Segment-Elevation Myocardial Infarction: A Novel Tool to Tailor Therapy or Emperor's New Clothes? Circ Cardiovasc Imaging 2017;10:e007108. [PMID: 29146588 DOI: 10.1161/CIRCIMAGING.117.007108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Mahmoud KD, Zijlstra F. Thrombus aspiration in acute myocardial infarction. Nat Rev Cardiol 2016;13:418-28. [DOI: 10.1038/nrcardio.2016.38] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
21 Gao S, Liu Q, Ding X, Chen H, Zhao X, Li H. Predictive value of the combination of age, creatinine, and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Coron Artery Dis 2020;31:109-17. [PMID: 31464730 DOI: 10.1097/MCA.0000000000000791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
22 Wang L, Su W, Xue J, Gong X, Dai Y, Chen J, Xue L, He P, Liu Y, Tan N. Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention. BMC Cardiovasc Disord 2021;21:404. [PMID: 34418967 DOI: 10.1186/s12872-021-02210-3] [Reference Citation Analysis]
23 Takagi K, Tanaka A, Morishima I, Morita Y, Yoshioka N, Yoshida R, Kanzaki Y, Watanabe N, Yamauchi R, Komeyama S, Sugiyama H, Shimojo K, Imaoka T, Sakamoto G, Ohi T, Goto H, Ishii H, Murohara T. Fifteen-year mortality and cardiac, thrombotic, and bleeding events in survivors of ST-elevation myocardial infarction. Cardiovasc Revasc Med 2021:S1553-8389(21)00211-6. [PMID: 33958307 DOI: 10.1016/j.carrev.2021.04.023] [Reference Citation Analysis]
24 Cheng Y, Li H, Li D, Liang L, Jia Y, Zou L, Li F, Zhu X, Qian H, He N, Zeng Z, Zeng R, Cao Y, Wan Z. Prognostic nutritional index may not be a good prognostic indicator for acute myocardial infarction. Sci Rep 2019;9:14717. [PMID: 31605003 DOI: 10.1038/s41598-019-51044-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Righetti S, Montemerlo E, Soffici F, Sala D, Bozzano A, Mauro A, Maggioni E, Avalli L, Camisasca P, Colombo V, Achilli F, Lettino M, Calchera I. Outcomes Related to Antiplatelet Therapy in a High-Risk ST-Segment Elevation Myocardial Infarction Population: A Retrospective Real-World Analysis of an Italian ECMO Center. J Cardiovasc Pharmacol Ther 2020;25:219-25. [PMID: 31868001 DOI: 10.1177/1074248419896129] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R; Local Health Unit group. All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study. Vasc Health Risk Manag 2018;14:383-92. [PMID: 30538488 DOI: 10.2147/VHRM.S162004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Gwag HB, Kim EK, Park TK, Lee JM, Yang JH, Song YB, Choi JH, Choi SH, Lee SH, Chang SA, Park SJ, Lee SC, Park SW, Jang WJ, Lee M, Chun WJ, Oh JH, Park YH, Choe YH, Gwon HC, Hahn JY. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial. J Am Heart Assoc 2017;6:e005426. [PMID: 28373244 DOI: 10.1161/JAHA.116.005426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
28 Arnold JR, McCann GP. Noninvasive Imaging Post-ST-Segment-Elevation Myocardial Infarction: Towards Targeted Therapy or Targeted End Points? Circ Cardiovasc Imaging 2017;10:e007179. [PMID: 29122842 DOI: 10.1161/CIRCIMAGING.117.007179] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Symons R, Pontone G, Schwitter J, Francone M, Iglesias JF, Barison A, Zalewski J, de Luca L, Degrauwe S, Claus P, Guglielmo M, Nessler J, Carbone I, Ferro G, Durak M, Magistrelli P, Lo Presti A, Aquaro GD, Eeckhout E, Roguelov C, Andreini D, Vogt P, Guaricci AI, Mushtaq S, Lorenzoni V, Muller O, Desmet W, Agati L, Janssens S, Bogaert J, Masci PG. Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Imaging 2018;11:813-25. [DOI: 10.1016/j.jcmg.2017.05.023] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 14.7] [Reference Citation Analysis]
30 王又和. 阿司匹林治疗冠心病患者合并上消化道出血的影响因素. 世界华人消化杂志 2017; 25(23): 2155-2160 [DOI: 10.11569/wcjd.v25.i23.2155] [Reference Citation Analysis]
31 Olivier CB, Sundaram V, Bhatt DL, Leonardi S, Lopes RD, Ding VY, Yang L, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, White HD, Desai M, Lynch DR Jr, Harrington RA, Mahaffey KW; CHAMPION PLATFORM and CHAMPION PCI Investigators. Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials. Int J Cardiol 2018;270:96-101. [PMID: 29937301 DOI: 10.1016/j.ijcard.2018.06.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
32 Daeter EJ, Timmermans MJC, Hirsch A, Lipsic E, Houterman S, van Veghel D, van der Nat PB; Meetbaar Beter advisory board. Defining and Measuring a Standard Set of Patient-Relevant Outcomes in Coronary Artery Disease. Am J Cardiol 2018;121:1477-88. [PMID: 29776654 DOI: 10.1016/j.amjcard.2018.02.037] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Pryds K, Hjortbak MV, Schmidt MR. Influence of Cardiovascular Risk Factors, Comorbidities, Medication Use and Procedural Variables on Remote Ischemic Conditioning Efficacy in Patients with ST-Segment Elevation Myocardial Infarction. Int J Mol Sci 2019;20:E3246. [PMID: 31269650 DOI: 10.3390/ijms20133246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Tai SB, Lau WR, Gao F, Hamid N, Amanullah MR, Fam JM, Yap J, Ewe SH, Chan MY, Yeo KK, Ding ZP, Sahlén A. E/e' in relation to outcomes in ST-elevation myocardial infarction. Echocardiography 2020;37:554-60. [PMID: 32242982 DOI: 10.1111/echo.14652] [Reference Citation Analysis]
35 Haanschoten DM, Elvan A, Ramdat Misier AR, Delnoy PPH, Smit JJJ, Adiyaman A, Demirel F, Wellens HJ, Verheugt FW, Ottervanger JP, Schalij M, Zijlstra F, Wever E, de Boer M, Boersma E, Robbe H. Long-Term Outcome of the Randomized DAPA Trial. Circ: Arrhythmia and Electrophysiology 2020;13. [DOI: 10.1161/circep.120.008484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
36 Doost Hosseiny A, Moloi S, Chandrasekhar J, Farshid A. Mortality pattern and cause of death in a long-term follow-up of patients with STEMI treated with primary PCI. Open Heart 2016;3:e000405. [PMID: 27099764 DOI: 10.1136/openhrt-2016-000405] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 5.4] [Reference Citation Analysis]
37 Lønborg J, Kelbæk H, Holmvang L, Helqvist S, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kløvgaard L, Kaltoft A, Bøtker H, Lassen JF, Clemmensen P, Terkelsen CJ, Engstrøm T. Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention. The American Journal of Cardiology 2016;117:1735-40. [DOI: 10.1016/j.amjcard.2016.03.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
38 Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, Collet J, Kristensen SD, Aboyans V, Baumbach A, Bugiardini R, Coman IM, Delgado V, Fitzsimons D, Gaemperli O, Gershlick AH, Gielen S, Harjola V, Katus HA, Knuuti J, Kolh P, Leclercq C, Lip GYH, Morais J, Neskovic AN, Neumann F, Niessner A, Piepoli MF, Richter DJ, Shlyakhto E, Simpson IA, Steg PG, Terkelsen CJ, Thygesen K, Windecker S, Zamorano JL, Zeymer U, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, Mcdonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL, Chettibi M, Hayrapetyan HG, Metzler B, Ibrahimov F, Sujayeva V, Beauloye C, Dizdarevic-hudic L, Karamfiloff K, Skoric B, Antoniades L, Tousek P, Terkelsen PJ, Shaheen SM, Marandi T, Niemelä M, Kedev S, Gilard M, Aladashvili A, Elsaesser A, Kanakakis IG, Merkely B, Gudnason T, Iakobishvili Z, Bolognese L, Berkinbayev S, Bajraktari G, Beishenkulov M, Zake I, Lamin HB, Gustiene O, Pereira B, Xuereb RG, Ztot S, Juliebø V, Legutko J, Timóteo AT, Tatu-chiţoiu G, Yakovlev A, Bertelli L, Nedeljkovic M, Studenčan M, Bunc M, García de Castro AM, Petursson P, Jeger R, Mourali MS, Yildirir A, Parkhomenko A, Gale CP; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal 2018;39:119-77. [DOI: 10.1093/eurheartj/ehx393] [Cited by in Crossref: 3294] [Cited by in F6Publishing: 2497] [Article Influence: 823.5] [Reference Citation Analysis]
39 Wang R, Mei B, Liao X, Lu X, Yan L, Lin M, Zhong Y, Chen Y, You T. Determination of risk factors affecting the in-hospital prognosis of patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention. BMC Cardiovasc Disord 2017;17:243. [PMID: 28899364 DOI: 10.1186/s12872-017-0660-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
40 Tang J, Chu J, Hou H, Lai Y, Tu S, Chen F, Yao Y, Ye Z, Gao Y, Mao Y, Zhuang S, Liu X. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation. Int J Cardiovasc Imaging 2021;37:755-66. [PMID: 33044717 DOI: 10.1007/s10554-020-02068-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I. Optimized Treatment of ST-Elevation Myocardial Infarction. Circ Res 2019;125:245-58. [PMID: 31268854 DOI: 10.1161/CIRCRESAHA.119.315344] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 25.0] [Reference Citation Analysis]
42 Hadanny A, Shouval R, Wu J, Shlomo N, Unger R, Zahger D, Matetzky S, Goldenberg I, Beigel R, Gale C, Iakobishvili Z. Predicting 30-day mortality after ST elevation myocardial infarction: Machine learning- based random forest and its external validation using two independent nationwide datasets. J Cardiol 2021:S0914-5087(21)00152-0. [PMID: 34154875 DOI: 10.1016/j.jjcc.2021.06.002] [Reference Citation Analysis]
43 Keenan J. Improving adherence to medication for secondary cardiovascular disease prevention. Eur J Prev Cardiolog 2017;24:29-35. [DOI: 10.1177/2047487317708145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
44 Frydland M, Møller JE, Lindholm MG, Hansen R, Wiberg S, Lerche Helgestad OK, Thomsen JH, Goetze JP, Engstrøm T, Frikke-schmidt R, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C. Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction. European Heart Journal. Acute Cardiovascular Care 2020;9:557-66. [DOI: 10.1177/2048872619896063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
45 Berton G, Cordiano R, Cavuto F, Bagato F, Segafredo B, Pasquinucci M. Neoplastic disease after acute coronary syndrome: incidence, duration, and features: the ABC-4* Study on Heart Disease. J Cardiovasc Med (Hagerstown) 2018;19:546-53. [PMID: 30119096 DOI: 10.2459/JCM.0000000000000701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
46 Raphael CE, Singh M, Bell M, Crusan D, Lennon RJ, Lerman A, Prasad A, Rihal CS, Gersh BJ, Gulati R. Sex Differences in Long-Term Cause-Specific Mortality After Percutaneous Coronary Intervention: Temporal Trends and Mechanisms. Circ Cardiovasc Interv 2018;11:e006062. [PMID: 29540493 DOI: 10.1161/CIRCINTERVENTIONS.117.006062] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
47 Chen M, Kan J, Zhang JJ, Tian N, Ye F, Yang S, Chen SL; MOODY Regustry study Investigators. Improvement of clinical outcome in patients with ST-elevation myocardial infarction between 1999 and 2016 in China: The Prospective, Multicentre Registry MOODY study. Eur J Clin Invest 2020;50:e13197. [PMID: 31883102 DOI: 10.1111/eci.13197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Andersson HB, Pedersen F, Engstrøm T, Helqvist S, Jensen MK, Jørgensen E, Kelbæk H, Räder SBEW, Saunamäki K, Bates E, Grande P, Holmvang L, Clemmensen P. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. European Heart Journal 2018;39:102-10. [DOI: 10.1093/eurheartj/ehx491] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
49 Rossello X, Yellon DM. A critical review on the translational journey of cardioprotective therapies! International Journal of Cardiology 2016;220:176-84. [DOI: 10.1016/j.ijcard.2016.06.131] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
50 Cenko E, Ricci B, Bugiardini R. STEMI: Prognosis. Encyclopedia of Cardiovascular Research and Medicine. Elsevier; 2018. pp. 489-98. [DOI: 10.1016/b978-0-12-809657-4.99745-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Bulluck H, Rosmini S, Abdel-Gadir A, Bhuva AN, Treibel TA, Fontana M, Weinmann S, Sirker A, Herrey AS, Manisty C, Moon JC, Hausenloy DJ. Impact of microvascular obstruction on semiautomated techniques for quantifying acute and chronic myocardial infarction by cardiovascular magnetic resonance. Open Heart 2016;3:e000535. [PMID: 28008358 DOI: 10.1136/openhrt-2016-000535] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
52 Quintana H, Janszky I, Gigante B, Druid H, Ahlbom A, Hallqvist J, de Faire U, Leander K. Diabetes, hypertension, overweight and hyperlipidemia and 7-day case-fatality in first myocardial infarction. IJC Metabolic & Endocrine 2016;12:30-5. [DOI: 10.1016/j.ijcme.2016.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
53 Kanjanahattakij N, Rattanawong P, Riangwiwat T, Prasitlumkum N, Limpruttidham N, Chongsathidkiet P, Vutthikraivit W, Crossey E. Fragmented QRS and mortality in patients undergoing percutaneous intervention for ST-elevation myocardial infarction: Systematic review and meta-analysis. Ann Noninvasive Electrocardiol 2018;23:e12567. [PMID: 29932268 DOI: 10.1111/anec.12567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
54 Reinstadler SJ, Eitel C, Thieme M, Metzler B, Poess J, Desch S, Thiele H, Eitel I. Comparison of Characteristics of Patients aged ≤45 Years Versus >45 Years With ST-Elevation Myocardial Infarction (from the AIDA STEMI CMR Substudy). Am J Cardiol 2016;117:1411-6. [PMID: 26965019 DOI: 10.1016/j.amjcard.2016.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
55 Mauri L, Elmariah S, Yeh RW, Cutlip DE, Steg PG, Windecker S, Wiviott SD, Cohen DJ, Massaro JM, D'Agostino RB Sr, Braunwald E, Kereiakes DJ; DAPT Study Investigators. Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J 2016;37:378-85. [PMID: 26586780 DOI: 10.1093/eurheartj/ehv614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wei P, Han B, Zhang WJ, Bai J, Jiang CY, Qiu CR, Zhang Q, Fu Q, Yang XJ. Effect of ticagrelor on the serum level of hs-CRP, ESM-1 and short-term prognosis of patients with acute STEMI. Exp Ther Med 2017;13:604-8. [PMID: 28352337 DOI: 10.3892/etm.2016.3987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
57 Wu Y, Fu X, Feng Q, Gu X, Hao G, Fan W, Jiang Y. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study. BMC Cardiovasc Disord 2020;20:308. [PMID: 32590944 DOI: 10.1186/s12872-020-01584-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Klein A, Wiberg S, Hassager C, Winther-Jensen M, Frikke-Schmidt R, Bang LE, Lindholm MG, Holmvang L, Moeller-Helgestad O, Ravn HB, Jensen LO, Kjaergaard J, Moeller JE, Frydland M. Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction. Shock 2020;53:299-306. [PMID: 31058719 DOI: 10.1097/SHK.0000000000001369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
59 Kotronias RA, Kwok CS, Wong CW, Kinnaird T, Zaman A, Mamas MA. Cancer Event Rate and Mortality with Thienopyridines: A Systematic Review and Meta-Analysis. Drug Saf 2017;40:229-40. [PMID: 28035491 DOI: 10.1007/s40264-016-0481-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
60 Marcos-Garces V, Gavara J, Lopez-Lereu MP, Monmeneu JV, Rios-Navarro C, de Dios E, Perez N, Cànoves J, Gonzalez J, Minana G, Nunez J, de la Espriella R, Santas E, Moratal D, Chorro FJ, Valente F, Lorenzatti D, Rodríguez-Palomares JF, Ortiz-Pérez JT, Bodi V. Ejection Fraction by Echocardiography for a Selective Use of Magnetic Resonance After Infarction. Circ Cardiovasc Imaging 2020;13:e011491. [PMID: 33297764 DOI: 10.1161/CIRCIMAGING.120.011491] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
61 Zhang H, Hu X, Wu Q, Shi B. Impact of diabetes on bleeding events in ST-elevation myocardial infarction patients after urgent percutaneous coronary intervention: A retrospective cohort study. Medicine (Baltimore) 2016;95:e4470. [PMID: 27537568 DOI: 10.1097/MD.0000000000004470] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Bromage DI, Pickard JM, Rossello X, Ziff OJ, Burke N, Yellon DM, Davidson SM. Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res 2017;113:288-97. [PMID: 28028069 DOI: 10.1093/cvr/cvw219] [Cited by in Crossref: 25] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
63 Siontis KC, Barsness GW, Lennon RJ, Holmen JL, Wright RS, Bell MR, Gersh BJ. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network). The American Journal of Cardiology 2016;117:1904-10. [DOI: 10.1016/j.amjcard.2016.03.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
64 Frydland M, Ostrowski SR, Møller JE, Hadziselimovic E, Holmvang L, Ravn HB, Jensen LO, Pettersson AS, Kjaergaard J, Lindholm MG, Johansson PI, Hassager C. Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock. Shock 2018;50:538-44. [DOI: 10.1097/shk.0000000000001123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 6.3] [Reference Citation Analysis]
65 Crişan S, Petriş AO, Petrescu L, Luca CT. Current Perspectives in Facilitated Angioplasty. Am J Ther 2019;26:e208-12. [PMID: 30839369 DOI: 10.1097/MJT.0000000000000914] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
66 Chuang AM, Hancock DG, Halabi A, Horsfall M, Vaile J, De Pasquale C, Sinhal A, Jones D, Brogan R, Chew DP. Invasive management of acute coronary syndrome: Interaction with competing risks. Int J Cardiol 2018;269:13-8. [PMID: 30037631 DOI: 10.1016/j.ijcard.2018.07.078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
67 Kobayashi A, Misumida N, Aoi S, Steinberg E, Kearney K, Fox JT, Kanei Y. STEMI notification by EMS predicts shorter door-to-balloon time and smaller infarct size. The American Journal of Emergency Medicine 2016;34:1610-3. [DOI: 10.1016/j.ajem.2016.06.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
68 Butt JH, Sørensen R, Bäck C, Olsen PS, Thorsteinsson K, Torp-Pedersen C, Gislason GH, Køber L, Fosbøl EL. Short- and long-term cause of death in patients undergoing isolated coronary artery bypass grafting: A nationwide cohort study. J Thorac Cardiovasc Surg 2018;156:54-60.e4. [PMID: 29627184 DOI: 10.1016/j.jtcvs.2018.01.106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Tran DT, Barake W, Galbraith D, Norris C, Knudtson ML, Kaul P, McAlister FA, Sandhu RK. Total and Cause-Specific Mortality After Percutaneous Coronary Intervention: Observations From the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease Registry. CJC Open 2019;1:182-9. [PMID: 32159105 DOI: 10.1016/j.cjco.2019.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Rerup SA, Bang LE, Mogensen UM, Engstrøm T, Jørgensen E, Pedersen F, Torp-Pedersen C, Gislason G, James S, Hagström E, Køber L, Fosbøl EL. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. Am Heart J 2016;181:35-42. [PMID: 27823691 DOI: 10.1016/j.ahj.2016.08.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
71 Luz A, Santos M, Magalhães R, Oliveira JC, Pacheco A, Silveira J, Cabral S, Torres S, Leite-moreira AF, Carvalho H. Soluble TNF-related apoptosis induced ligand (sTRAIL) is augmented by Post-Conditioning and correlates to infarct size and left ventricle dysfunction in STEMI patients: a substudy from a randomized clinical trial. Heart Vessels 2017;32:117-25. [DOI: 10.1007/s00380-016-0851-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
72 Ferrieres J, De Ferrari GM, Hermans MP, Elisaf M, Toth PP, Horack M, Brudi P, Lautsch D, Bash LD, Baxter CA, Ashton V, Ambegaonkar B, Gitt AK. Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II Europe. Eur J Prev Cardiolog 2018;25:1966-76. [DOI: 10.1177/2047487318806359] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
73 Entezarjou A, Mohammad MA, Andell P, Koul S. Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction. Open Heart 2018;5:e000852. [PMID: 30228908 DOI: 10.1136/openhrt-2018-000852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Lanzer P, Widimský P. Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach. Eur Heart J 2015;36:2348-55. [DOI: 10.1093/eurheartj/ehv217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
75 Coelho-Lima J, Mohammed A, Cormack S, Jones S, Ali A, Panahi P, Barter M, Bagnall A, Ali S, Young D, Spyridopoulos I. Kinetics Analysis of Circulating MicroRNAs Unveils Markers of Failed Myocardial Reperfusion. Clin Chem 2020;66:247-56. [PMID: 31672851 DOI: 10.1373/clinchem.2019.308353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
76 Zachura M, Wilczek K, Janion M, Gąsior M, Gierlotka M, Sadowski M. Long-term outcomes in men and women with ST-segment elevation myocardial infarction and incomplete reperfusion after a primary percutaneous coronary intervention: a 2-year follow-up. Coronary Artery Disease 2019;30:171-6. [DOI: 10.1097/mca.0000000000000703] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Du X, You H, Li Y, Wang Y, Hui P, Qiao B, Lu J, Zhang W, Zhou S, Zheng Y, Du J. Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI. Sci Rep 2018;8:15809. [PMID: 30361499 DOI: 10.1038/s41598-018-34245-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
78 Bauters C, Tricot O, Meurice T, Lamblin N. Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study. Coronary Artery Disease 2017;28:636-41. [DOI: 10.1097/mca.0000000000000560] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
79 Bossard M, Mehta SR. Complete or Incomplete Revascularization for ST-Segment Elevation Myocardial Infarction: The PRAMI Trial to COMPLETE. Interv Cardiol Clin 2020;9:433-40. [PMID: 32921367 DOI: 10.1016/j.iccl.2020.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Hizoh I, Banhegyi G, Domokos D, Gulyas Z, Major L, Kiss RG. Impact of Selective Aspiration Thrombectomy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Am J Cardiol 2018;121:796-804. [PMID: 29397104 DOI: 10.1016/j.amjcard.2017.12.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Sans-Roselló J, Casals G, Rossello X, González de la Presa B, Vila M, Duran-Cambra A, Morales-Ruiz M, Ferrero-Gregori A, Jiménez W, Sionis A. Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction. Clin Biochem 2017;50:279-84. [PMID: 27889567 DOI: 10.1016/j.clinbiochem.2016.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
82 Watanabe H, Ozasa N, Morimoto T, Shiomi H, Bingyuan B, Suwa S, Nakagawa Y, Izumi C, Kadota K, Ikeguchi S, Hibi K, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Hayashi Y, Nanasato M, Okutsu M, Kametani R, Sone T, Sugimura Y, Kawai K, Abe M, Kaneko H, Nakamura S, Kimura T; CAPITAL-RCT investigators. Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. PLoS One 2018;13:e0199347. [PMID: 30153268 DOI: 10.1371/journal.pone.0199347] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
83 Mohl W, Gangl C, Jusić A, Aschacher T, De Jonge M, Rattay F. PICSO: from myocardial salvage to tissue regeneration. Cardiovascular Revascularization Medicine 2015;16:36-46. [DOI: 10.1016/j.carrev.2014.12.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
84 Laursen PN, Holmvang L, Kelbæk H, Vejlstrup N, Engstrøm T, Lønborg J. Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints. Clin Res Cardiol 2017;106:525-32. [DOI: 10.1007/s00392-017-1081-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
85 Yoshioka N, Takagi K, Tanaka A, Morita Y, Yoshida R, Kanzaki Y, Nagai H, Watanabe N, Yamauchi R, Komeyama S, Sugiyama H, Shimojo K, Imaoka T, Sakamoto G, Ohi T, Goto H, Ishii H, Morishima I, Murohara T. The Mid-term Mortality and Mode of Death in Survivors with ST-elevation Myocardial Infarction. Intern Med 2021;60:1665-74. [PMID: 33390500 DOI: 10.2169/internalmedicine.6549-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Bukhari S, Fatima S, Elgendy IY. Cardiogenic shock in the setting of acute myocardial infarction: Another area of sex disparity? World J Cardiol 2021; 13(6): 170-176 [PMID: 34194635 DOI: 10.4330/wjc.v13.i6.170] [Reference Citation Analysis]
87 Qiu C, Fu Q, Sui J, Zhang Q, Wei P, Wu Y, Zhu K, Lu Y, Zong B. Serum Endothelial Cell–Specific Molecule 1 (Endocan) Levels in Patients With Acute Myocardial Infarction and Its Clinical Significance: A Pilot Study. Angiology 2017;68:354-9. [DOI: 10.1177/0003319716651349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
88 Isogai T, Matsui H, Tanaka H, Yokogawa N, Fushimi K, Yasunaga H. Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan. Clin Rheumatol 2017;36:995-1004. [PMID: 28124758 DOI: 10.1007/s10067-017-3555-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
89 Malik A, Bromage DI, He Z, Candilio L, Hamarneh A, Taferner S, Davidson SM, Yellon DM. Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4. Cardiovasc Drugs Ther 2015;29:589-92. [PMID: 26482377 DOI: 10.1007/s10557-015-6622-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
90 Shouval R, Hadanny A, Shlomo N, Iakobishvili Z, Unger R, Zahger D, Alcalai R, Atar S, Gottlieb S, Matetzky S, Goldenberg I, Beigel R. Machine learning for prediction of 30-day mortality after ST elevation myocardial infraction: An Acute Coronary Syndrome Israeli Survey data mining study. Int J Cardiol 2017;246:7-13. [PMID: 28867023 DOI: 10.1016/j.ijcard.2017.05.067] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
91 Brainin P, Haahr-Pedersen S, Olsen FJ, Holm AE, Fritz-Hansen T, Jespersen T, Gislason G, Biering-Sørensen T. Early Systolic Lengthening in Patients With ST-Segment-Elevation Myocardial Infarction: A Novel Predictor of Cardiovascular Events. J Am Heart Assoc 2020;9:e013835. [PMID: 31973603 DOI: 10.1161/JAHA.119.013835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
92 Yan F, Liu H, Jiang W. Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST elevation myocardial infarction: A systematic review and meta-analysis protocol. Medicine (Baltimore) 2019;98:e16226. [PMID: 31261578 DOI: 10.1097/MD.0000000000016226] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Lee CH, Lin HW, Lee NY, Lin SH, Li YH. Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel. Eur J Intern Med 2021;85:121-3. [PMID: 33199177 DOI: 10.1016/j.ejim.2020.10.016] [Reference Citation Analysis]
94 Josiassen J, Helgestad OKL, Møller JE, Holmvang L, Jensen LO, Udesen NLJ, Ravn HB, Hassager C. Prognostic importance of culprit lesion location in cardiogenic shock due to myocardial infarction. European Heart Journal. Acute Cardiovascular Care 2021;10:25-32. [DOI: 10.1177/2048872620911848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Yamashita Y, Shiomi H, Morimoto T, Yaku H, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Abe M, Nagao K, Shizuta S, Ono K, Kimura T. Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment–Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention. Circ: Cardiovascular Quality and Outcomes 2017;10. [DOI: 10.1161/circoutcomes.116.002790] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
96 Acet H, Güzel T, Aslan B, Isik MA, Ertas F, Catalkaya S. Predictive Value of C-Reactive Protein to Albumin Ratio in ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention. Angiology 2021;72:244-51. [PMID: 33371718 DOI: 10.1177/0003319720963697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Reinstadler SJ, Stiermaier T, Fuernau G, de Waha S, Desch S, Metzler B, Thiele H, Eitel I. The challenges and impact of microvascular injury in ST-elevation myocardial infarction. Expert Review of Cardiovascular Therapy 2016;14:431-43. [DOI: 10.1586/14779072.2016.1135055] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
98 Moscarella E, Brugaletta S, Sabaté M. Latest STEMI treatment: a focus on current and upcoming devices. Expert Review of Medical Devices 2018;15:807-17. [DOI: 10.1080/17434440.2018.1538778] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
99 Ahmed N, Carberry J, Teng V, Carrick D, Berry C. Risk assessment in patients with an acute ST-elevation myocardial infarction. J Comp Eff Res 2016;5:581-93. [PMID: 27580675 DOI: 10.2217/cer-2016-0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
100 Reinstadler SJ, Metzler B. Myocardial Damage After Primary PCI: Does Obesity Really Matter? JACC Cardiovasc Interv 2020;13:973-5. [PMID: 32327094 DOI: 10.1016/j.jcin.2020.02.037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Butcher SC, Lustosa RP, Abou R, Marsan NA, Bax JJ, Delgado V. Prognostic implications of left ventricular myocardial work index in patients with ST-segment elevation myocardial infarction and reduced left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 2021:jeab096. [PMID: 33993227 DOI: 10.1093/ehjci/jeab096] [Reference Citation Analysis]
102 Ito H, Masuda J, Kurita T, Ida M, Yamamoto A, Takasaki A, Takeuchi T, Sato Y, Omura T, Sawai T, Tanigawa T, Ito M, Dohi K. Effect of left ventricular ejection fraction on the prognostic impact of chronic total occlusion in a non-infarct-related artery in patients with acute myocardial infarction. Int J Cardiol Heart Vasc 2021;33:100738. [PMID: 33718588 DOI: 10.1016/j.ijcha.2021.100738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Compostella L, Lorenzi S, Russo N, Setzu T, Compostella C, Vettore E, Isabella G, Tarantini G, Iliceto S, Bellotto F. Depressive symptoms, functional measures and long-term outcomes of high-risk ST-elevated myocardial infarction patients treated by primary angioplasty. Intern Emerg Med 2017;12:31-43. [DOI: 10.1007/s11739-016-1504-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
104 Vaidya K, Tucker B, Patel S, Ng MKC. Acute Coronary Syndromes (ACS)-Unravelling Biology to Identify New Therapies-The Microcirculation as a Frontier for New Therapies in ACS. Cells 2021;10:2188. [PMID: 34571836 DOI: 10.3390/cells10092188] [Reference Citation Analysis]
105 Zandecki Ł, Sadowski M, Janion M, Kurzawski J, Gierlotka M, Poloński L, Gąsior M. Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions. Cardiol J 2019;26:459-68. [PMID: 29924379 DOI: 10.5603/CJ.a2018.0057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Ran P, Wei XB, Lin YW, Li G, Huang JL, He XY, Yang JQ, Yu DQ, Chen JY. Shock Index-C: An Updated and Simple Risk-Stratifying Tool in ST-Segment Elevation Myocardial Infarction. Front Cardiovasc Med 2021;8:657817. [PMID: 34212012 DOI: 10.3389/fcvm.2021.657817] [Reference Citation Analysis]
107 Pascual I, Hernandez-Vaquero D, Almendarez M, Lorca R, Escalera A, Díaz R, Alperi A, Carnero M, Silva J, Morís C, Avanzas P. Observed and Expected Survival in Men and Women After Suffering a STEMI. J Clin Med 2020;9:E1174. [PMID: 32325887 DOI: 10.3390/jcm9041174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
108 Kvakkestad KM, Wang Fagerland M, Eritsland J, Halvorsen S. Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study. BMC Cardiovasc Disord 2017;17:75. [PMID: 28288586 DOI: 10.1186/s12872-017-0508-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
109 Meng H, Wang X, Ruan J, Chen W, Meng F, Yang P. High Expression Levels of the SOCS3 Gene Are Associated with Acute Myocardial Infarction. Genet Test Mol Biomarkers 2020;24:443-50. [PMID: 32589469 DOI: 10.1089/gtmb.2020.0040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology. Basic Res Cardiol 2018;113:43. [PMID: 30310998 DOI: 10.1007/s00395-018-0704-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 19.7] [Reference Citation Analysis]
111 Pascual I, Avanzas P, Almendárez M, Lorca R, Vigil-Escalera M, Arboine L, Alperi A, Adeba A, Díaz R, Silva J, Morís C, Hernández-Vaquero D. STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study. Rev Esp Cardiol (Engl Ed) 2021;74:829-37. [PMID: 32978098 DOI: 10.1016/j.rec.2020.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Laursen PN, Nepper-christensen L, Clemmensen P, Møller-helgestad OK, Sørensen R, Ravkilde J, Terkelsen CJ, Jørgensen E, Saunamäki K, Tilsted H, Kelbæk H, Holmvang L. Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy). The American Journal of Cardiology 2018;121:781-8. [DOI: 10.1016/j.amjcard.2017.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
113 Fraticelli L, Kleitz O, Claustre C, Eydoux N, Peiretti A, Tazarourte K, Bonnefoy-Cudraz E, Dussart C, El Khoury C; RESCUe Research Group. Comparison of the pathways of care and life courses between first-time ST-elevation myocardial infarction (STEMI) and STEMI with prior MI: findings from the OSCAR registry. BMJ Open 2020;10:e038773. [PMID: 33154054 DOI: 10.1136/bmjopen-2020-038773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Piuhola J, Holmström LTA, Niemelä M, Kervinen K, Tulppo M, Asikainen R, Hypèn L, Junttila MJ. Three-year outcomes related to coronary stenting; a registry-based real-life population study. Scand Cardiovasc J 2020;54:162-8. [PMID: 31752551 DOI: 10.1080/14017431.2019.1693057] [Reference Citation Analysis]
115 Demirkiran A, Everaars H, Amier RP, Beijnink C, Bom MJ, Götte MJW, van Loon RB, Selder JL, van Rossum AC, Nijveldt R. Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury. Eur Heart J Cardiovasc Imaging 2019;20:723-34. [PMID: 31131401 DOI: 10.1093/ehjci/jez094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
116 Alabas OA, Hall M, Dondo TB, Rutherford MJ, Timmis AD, Batin PD, Deanfield JE, Hemingway H, Gale CP. Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. J Epidemiol Community Health 2017;71:25-32. [PMID: 27307468 DOI: 10.1136/jech-2016-207402] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
117 Rossello X, Lobo-Gonzalez M, Ibanez B. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome. Eur Heart J Acute Cardiovasc Care 2019;8:443-56. [PMID: 31172789 DOI: 10.1177/2048872619845283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
118 Piepoli MF, Corrà U, Dendale P, Frederix I, Prescott E, Schmid JP, Cupples M, Deaton C, Doherty P, Giannuzzi P, Graham I, Hansen TB, Jennings C, Landmesser U, Marques-vidal P, Vrints C, Walker D, Bueno H, Fitzsimons D, Pelliccia A. Challenges in secondary prevention after acute myocardial infarction: A call for action. European Journal of Cardiovascular Nursing 2017;16:369-80. [DOI: 10.1177/1474515117702594] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
119 Hamm W, Rizas K, Bauer A. Ischämische Kardiomyopathie: Marker des autonomen Tonus. Herzschr Elektrophys 2015;26:12-6. [DOI: 10.1007/s00399-015-0352-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Piepoli MF, Corrà U, Dendale P, Frederix I, Prescott E, Schmid JP, Cupples M, Deaton C, Doherty P, Giannuzzi P, Graham I, Hansen TB, Jennings C, Landmesser U, Marques-Vidal P, Vrints C, Walker D, Bueno H, Fitzsimons D, Pelliccia A. Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur Heart J Acute Cardiovasc Care 2017;6:299-310. [PMID: 28608759 DOI: 10.1177/2048872616689773] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
121 Gaudino M, Hameed I, Farkouh ME, Rahouma M, Naik A, Robinson NB, Ruan Y, Demetres M, Biondi-Zoccai G, Angiolillo DJ, Bagiella E, Charlson ME, Benedetto U, Ruel M, Taggart DP, Girardi LN, Bhatt DL, Fremes SE. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis. JAMA Intern Med 2020;180:1638-46. [PMID: 33044497 DOI: 10.1001/jamainternmed.2020.4748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
122 Scherrenberg M, Janssen J, Lauwers A, Schreurs I, Swinnen M, Dendale P. Is there an optimal dose of cardiac rehabilitation in coronary artery disease patients? Int J Cardiol 2021;330:7-11. [PMID: 33545262 DOI: 10.1016/j.ijcard.2021.01.065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Yang L, Zheng T, Wu H, Xin W, Mou X, Lin H, Chen Y, Wu X. Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study. BMJ Open 2017;7:e018595. [PMID: 29150476 DOI: 10.1136/bmjopen-2017-018595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
124 Bărcan A, Chițu M, Benedek E, Rat N, Korodi S, Morariu M, Kovacs I. Predictors of Mortality in Patients with ST-Segment Elevation Acute Myocardial Infarction and Resuscitated Out-of-Hospital Cardiac Arrest. J Crit Care Med (Targu Mures) 2016;2:22-9. [PMID: 29967833 DOI: 10.1515/jccm-2016-0001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
125 Jia Y, Gao Y, Li D, Cao Y, Cheng Y, Li F, Xiao L, Jiang Y, Wan Z, Zeng Z, Zeng R. Geriatric Nutritional Risk Index Score Predicts Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction. J Cardiovasc Nurs 2020;35:E44-52. [DOI: 10.1097/jcn.0000000000000674] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
126 Wang F, Gulati R, Lennon RJ, Lewis BR, Park J, Sandhu GS, Wright RS, Lerman A, Herrmann J. Cancer History Portends Worse Acute and Long-term Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction. Mayo Clinic Proceedings 2016;91:1680-92. [DOI: 10.1016/j.mayocp.2016.06.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
127 Holzknecht M, Reindl M, Tiller C, Reinstadler SJ, Lechner I, Pamminger M, Schwaiger JP, Klug G, Bauer A, Metzler B, Mayr A. Global longitudinal strain improves risk assessment after ST-segment elevation myocardial infarction: a comparative prognostic evaluation of left ventricular functional parameters. Clin Res Cardiol 2021. [PMID: 33884479 DOI: 10.1007/s00392-021-01855-6] [Reference Citation Analysis]
128 Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Déry JP, Harvey R, De LaRocheliere R, Cantin B, Schampaert E, Tardif JC. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study). Am J Cardiol 2018;121:897-902. [PMID: 29452691 DOI: 10.1016/j.amjcard.2017.12.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
129 Dahal K, Hendrani A, Sharma SP, Singireddy S, Mina G, Reddy P, Dominic P, Modi K. Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis. JAMA Intern Med 2018;178:913-20. [PMID: 29799995 DOI: 10.1001/jamainternmed.2018.0850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
130 Lourbopoulos A, Mourouzis I, Xinaris C, Zerva N, Filippakis K, Pavlopoulos A, Pantos C. Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal. Front Neurosci 2021;15:652403. [PMID: 34054413 DOI: 10.3389/fnins.2021.652403] [Reference Citation Analysis]
131 Thoegersen M, Josiassen J, Helgestad OK, Berg Ravn H, Schmidt H, Holmvang L, Jensen LO, Møller JE, Hassager C. The association of diabetes and admission blood glucose with 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2020;9:626-35. [PMID: 32450719 DOI: 10.1177/2048872620925265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Sandø A, Schultz M, Eugen-Olsen J, Køber L, Engstrøm T, Kelbæk H, Jørgensen E, Saunamäki K, Holmvang L, Pedersen F, Tilsted HH, Høfsten D, Helqvist S, Clemmensen P, Iversen K. Soluble urokinase receptor as a predictor of non-cardiac mortality in patients with percutaneous coronary intervention treated ST-segment elevation myocardial infarction. Clin Biochem 2020;80:8-13. [PMID: 32213303 DOI: 10.1016/j.clinbiochem.2020.03.013] [Reference Citation Analysis]
133 Dogan A, Kahraman S. Frontal QRS-T angle predicts coronary atherosclerotic burden in patients with ST segment elevation myocardial infarction. Journal of Electrocardiology 2020;58:155-9. [DOI: 10.1016/j.jelectrocard.2019.11.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
134 García-García C, Ribas N, Recasens LL, Meroño O, Subirana I, Fernández A, Pérez A, Miranda F, Tizón-Marcos H, Martí-Almor J, Bruguera J, Elosua R. In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. "Head to head" analisys: invasive reperfusion vs optimal medical therapy. BMC Cardiovasc Disord 2017;17:139. [PMID: 28549452 DOI: 10.1186/s12872-017-0574-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
135 Jensen RV, Hjortbak MV, Bøtker HE. Ischemic Heart Disease: An Update. Seminars in Nuclear Medicine 2020;50:195-207. [DOI: 10.1053/j.semnuclmed.2020.02.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
136 Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J. Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction. Heart 2020;106:24-32. [PMID: 31315939 DOI: 10.1136/heartjnl-2019-314952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
137 Bodde MC, Hermans MPJ, van der Laarse A, Mertens B, Romijn FPHTM, Schalij MJ, Cobbaert CM, Jukema JW. Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Cardiol Ther 2019;8:29-41. [PMID: 30701401 DOI: 10.1007/s40119-019-0127-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
138 Compostella L, Lakusic N, Russo N, Setzu T, Compostella C, Vettore E, Isabella G, Tarantini G, Iliceto S, Bellotto F. Functional parameters but not heart rate variability correlate with long-term outcomes in St-elevation myocardial infarction patients treated by primary angioplasty. Int J Cardiol 2016;224:473-81. [PMID: 27736721 DOI: 10.1016/j.ijcard.2016.09.070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
139 Fan J, Wang X, Ma X, Somers VK, Nie S, Wei Y. Association of Obstructive Sleep Apnea With Cardiovascular Outcomes in Patients With Acute Coronary Syndrome. J Am Heart Assoc 2019;8:e010826. [PMID: 30636505 DOI: 10.1161/JAHA.118.010826] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
140 Fisher S, Doree C, Taggart D, Mathur A, Martin-rendon E. Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews. Clin Pharmacol Ther 2016;100:88-101. [DOI: 10.1002/cpt.344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
141 Zarà M, Campodonico J, Cosentino N, Biondi ML, Amadio P, Milanesi G, Assanelli E, Cerri S, Biggiogera M, Sandrini L, Tedesco CC, Veglia F, Trabattoni D, Blandini F, Tremoli E, Marenzi G, Barbieri SS. Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest. Int J Mol Sci 2021;22:8065. [PMID: 34360827 DOI: 10.3390/ijms22158065] [Reference Citation Analysis]
142 Kloner RA, Shi J, Dai W. New therapies for reducing post-myocardial left ventricular remodeling. Ann Transl Med 2015;3:20. [PMID: 25738140 DOI: 10.3978/j.issn.2305-5839.2015.01.13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
143 Bai Y, Zheng YY, Tang JN, Yang XM, Guo QQ, Zhang JC, Cheng MD, Song FH, Wang K, Zhang ZL, Liu ZY, Jiang LZ, Fan L, Yue XT, Dai XY, Zheng RJ, Zhang JY. D-Dimer to Fibrinogen Ratio as a Novel Prognostic Marker in Patients After Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study. Clin Appl Thromb Hemost 2020;26:1076029620948586. [PMID: 32842770 DOI: 10.1177/1076029620948586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
144 Frederix I, Dendale P, Sheikh A. FIT@Home editorial: Supporting a new era of cardiac rehabilitation at home? European Journal of Preventive Cardiology 2017;24:1485-7. [DOI: 10.1177/2047487317715308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
145 Boyle AJ, Schultz C, Selvanayagam JB, Moir S, Kovacs R, Dib N, Zlotnick D, Al-Omary M, Sugito S, Selvarajah A, Collins N, McLachlan G. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol 2021;6:762-8. [PMID: 33851966 DOI: 10.1001/jamacardio.2021.0676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
146 Baumert B, Przybycień K, Paczkowska E, Kotowski M, Pius-Sadowska E, Safranow K, Peregud-Pogorzelski J, Kornacewicz-Jach Z, Peregud-Pogorzelska M, Machaliński B. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction. Int J Mol Sci 2019;20:E3330. [PMID: 31284593 DOI: 10.3390/ijms20133330] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
147 Zhou B, Xiao M, Hu H, Pei X, Xue Y, Miao G, Wang J, Li W, Du Y, Zhang P, Wei T. Cardioprotective Role of SIRT5 in Response to Acute Ischemia Through a Novel Liver-Cardiac Crosstalk Mechanism. Front Cell Dev Biol 2021;9:687559. [PMID: 34368135 DOI: 10.3389/fcell.2021.687559] [Reference Citation Analysis]
148 Takagi K, Tanaka A, Yoshioka N, Morita Y, Yoshida R, Kanzaki Y, Watanabe N, Yamauchi R, Komeyama S, Sugiyama H, Shimojo K, Imaoka T, Sakamoto G, Ohi T, Goto H, Ishii H, Morishima I, Murohara T. In-hospital mortality among consecutive patients with ST-Elevation myocardial infarction in modern primary percutaneous intervention era ~ Insights from 15-year data of single-center hospital-based registry ~. PLoS One 2021;16:e0252503. [PMID: 34115767 DOI: 10.1371/journal.pone.0252503] [Reference Citation Analysis]
149 Piepoli MF, Corrà U, Dendale P, Frederix I, Prescott E, Schmid JP, Cupples M, Deaton C, Doherty P, Giannuzzi P, Graham I, Hansen TB, Jennings C, Landmesser U, Marques-vidal P, Vrints C, Walker D, Bueno H, Fitzsimons D, Pelliccia A. Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Prev Cardiolog 2016;23:1994-2006. [DOI: 10.1177/2047487316663873] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 15.0] [Reference Citation Analysis]
150 Ekström K, Nepper-christensen L, Ahtarovski KA, Kyhl K, Göransson C, Bertelsen L, Ghotbi AA, Kelbæk H, Helqvist S, Høfsten DE, Køber L, Schoos MM, Vejlstrup N, Lønborg J, Engstrøm T. Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI. JACC: Cardiovascular Imaging 2019;12:2168-78. [DOI: 10.1016/j.jcmg.2019.01.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
151 Bromage DI, Godec TR, Pujades-Rodriguez M, Gonzalez-Izquierdo A, Denaxas S, Hemingway H, Yellon DM. Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study. Cardiovasc Diabetol 2019;18:168. [PMID: 31815634 DOI: 10.1186/s12933-019-0972-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
152 Isogai T, Matsui H, Tanaka H, Fushimi K, Yasunaga H. Atrial natriuretic peptide therapy and in-hospital mortality in acute myocardial infarction patients undergoing percutaneous coronary intervention. International Journal of Cardiology 2016;222:163-70. [DOI: 10.1016/j.ijcard.2016.07.159] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
153 Geng W, Zhang Q, Liu J, Tian X, Zhen L, Song D, Yang Y, Meng H, Wang Y, Chen J. A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. J Interv Cardiol 2018;31:136-43. [PMID: 29171086 DOI: 10.1111/joic.12461] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
154 Li N, Huang Z, Zhang Y, Sun H, Wang J, Zhao J. Increased cancer risk after myocardial infarction: fact or fiction? A systemic review and meta-analysis. Cancer Manag Res 2019;11:1959-68. [PMID: 30881121 DOI: 10.2147/CMAR.S193658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
155 Liu Z, Liu L, Cheng J, Zhang H. Risk Prediction Model Based on Biomarkers of Remodeling in Patients with Acute Anterior ST-Segment Elevation Myocardial Infarction. Med Sci Monit 2021;27:e927404. [PMID: 34282109 DOI: 10.12659/MSM.927404] [Reference Citation Analysis]
156 Dyrbuś K, Gąsior M, Desperak P, Trzeciak P, Nowak J, Penson PE, Osadnik T, Banach M. Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry. Atherosclerosis 2021;333:16-23. [PMID: 34418681 DOI: 10.1016/j.atherosclerosis.2021.08.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]